Despite progress in pre-hospital care, ambulance logistics, pharmacotherapy and PPCI techniques, ST-segment elevation myocardial infarction (STEMI) continues to confer a substantial burden of morbidity and mortality. Within the STEMI population, there is a spectrum of higher and lower risk patients. The aim of this cohort study is to collect prospectively and systematically clinical research data from STEMI patients. This cohort study is an open-end observational study to identify master switches in myocardial ischemia.
Study Type
OBSERVATIONAL
Enrollment
1,000
prospectively and systematically collection of clinical research data from STEMI patients
Division of Cardiology, Pulmonary Disease and Vascular Medicine
Düsseldorf, Germany
RECRUITINGLeft-ventricular function
* LV-EF \< 40% at 6 months * Δ LV-EF ≥ 5% between day 5 of hospitalization and 6 months
Time frame: 6 months
Left-ventricular remodeling
Δ LVEDV ≥ 20% or Δ LVESV ≥ 15% between day 5 of hospitalization and 6 months
Time frame: 6 months
Myocardial texture
* Infarct/Scar size \> 17.9% or MVO (yes) or IMH (yes) on day 5 of hospitalization or at 6 months * remote zone ΔECV between day 5 of hospitalization and 6 months
Time frame: on day 5 of hospitalization and 6 months
Patency rate
Coronary patency rate
Time frame: 6 months
All cause mortaltiy
All cause mortaltiy
Time frame: 12 months
MACCE
cardiovascular death, non-fatal stroke or myocardial infarction
Time frame: 12 months
Re-Hospitalisation due to heart failure
Re-Hospitalisation due to heart failure
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.